Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older who have been diagnosed with hepatocellular carcinoma (liver cancer) and have recently experienced bleeding from enlarged veins in the esophagus or stomach, where that bleeding was successfully treated within the past 4 weeks using standard procedures such as band ligation or glue injection
- People who are able to give written consent to take part and follow the study procedures
Who may not be able to join:
- People who are unable to give written consent to participate
- People whose other health conditions make it unsafe for them to undergo an endoscopy (a camera procedure)
- People with liver cancer whose gastrointestinal bleeding came from a source other than enlarged veins
- People with severely abnormal blood clotting or very low platelet counts that have not improved after receiving blood products (confirm with trial site for specific thresholds)
- People who are critically unwell due to a terminal illness with very limited life expectancy
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Raymond S Tang, MD, Chinese University of Hong Kong
Phone: (852) 26370428
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
90-day death adjusted cumulative incidence of variceal rebleeding after secondary prevention by EUS-guided therapy or conventional endoscopic therapy
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.